Voyager Therapeutics, Inc. — Director's Dealing 2025

Aug 20, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Voyager Therapeutics, Inc. (VYGR)
CIK: 0001640266
Period of Report: 2025-08-18

Reporting Person: Ferguson Toby (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-18	Common Stock	S	19000	$3.73	Disposed	138914	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.79, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.